{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:35:22Z","timestamp":1791858922413,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270591"],"award-info":[{"award-number":["81270591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670132"],"award-info":[{"award-number":["81670132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL115187-01A1"],"award-info":[{"award-number":["R01HL115187-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00277-017-3092-9","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T10:51:44Z","timestamp":1502448704000},"page":"1849-1855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation"],"prefix":"10.1007","volume":"96","author":[{"given":"Jiaqian","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgeng","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"issue":"3","key":"3092_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","volume":"29","author":"S Jodele","year":"2015","unstructured":"Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, Goebel J, Dixon BP (2015) A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev 29(3):191\u2013204. doi:\n                    10.1016\/j.blre.2014.11.001","journal-title":"Blood Rev"},{"issue":"4","key":"3092_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J, Wallace G, Chima RS, Paff Z, Laskin BL (2014) Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood 124(4):645\u2013653. doi:\n                    10.1182\/blood-2014-03-564997","journal-title":"Blood"},{"issue":"2","key":"3092_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2215\/CJN.02070508","volume":"4","author":"S Changsirikulchai","year":"2009","unstructured":"Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR (2009) Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 4(2):345\u2013353. doi:\n                    10.2215\/CJN.02070508","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3092_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","volume":"85","author":"K Siami","year":"2008","unstructured":"Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG (2008) Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 85(1):22\u201328. doi:\n                    10.1097\/01.tp.0000297998.33418.7e","journal-title":"Transplantation"},{"issue":"11","key":"3092_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/bmt.2008.7","volume":"41","author":"JN George","year":"2008","unstructured":"George JN (2008) Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder. Bone Marrow Transplant 41(11):917\u2013918. doi:\n                    10.1038\/bmt.2008.7","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"3092_CR6","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S (2011) Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 118(6):1452\u20131462. doi:\n                    10.1182\/blood-2011-02-321315","journal-title":"Blood"},{"issue":"6","key":"3092_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/bmt.2008.350","volume":"43","author":"J Thachil","year":"2009","unstructured":"Thachil J (2009) Nitric oxide in transplantation-related thrombotic microangiopathy. Bone Marrow Transplant 43(6):513\u2013514. doi:\n                    10.1038\/bmt.2008.350","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3092_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.immuni.2012.08.002","volume":"37","author":"MC Carroll","year":"2012","unstructured":"Carroll MC, Isenman DE (2012) Regulation of humoral immunity by complement. Immunity 37(2):199\u2013207. doi:\n                    10.1016\/j.immuni.2012.08.002","journal-title":"Immunity"},{"issue":"12","key":"3092_CR9","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.addr.2011.05.023","volume":"63","author":"T Vorup-Jensen","year":"2011","unstructured":"Vorup-Jensen T, Boesen T (2011) Protein ultrastructure and the nanoscience of complement activation. Adv Drug Deliv Rev 63(12):1008\u20131019. doi:\n                    10.1016\/j.addr.2011.05.023","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3092_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/01.RES.0000255032.33661.88","volume":"100","author":"J Wehner","year":"2007","unstructured":"Wehner J, Morrell CN, Reynolds T, Rodriguez ER, Baldwin WM 3rd (2007) Antibody and complement in transplant vasculopathy. Circ Res 100(2):191\u2013203. doi:\n                    10.1161\/01.RES.0000255032.33661.88","journal-title":"Circ Res"},{"issue":"4","key":"3092_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060352","volume":"8","author":"LV Holmes","year":"2013","unstructured":"Holmes LV, Strain L, Staniforth SJ, Moore I, Marchbank K, Kavanagh D, Goodship JA, Cordell HJ, Goodship TH (2013) Determining the population frequency of the CFHR3\/CFHR1 deletion at 1q32. PLoS One 8(4):e60352. doi:\n                    10.1371\/journal.pone.0060352","journal-title":"PLoS One"},{"issue":"8","key":"3092_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","volume":"127","author":"S Jodele","year":"2016","unstructured":"Jodele S, Zhang K, Zou F, Laskin B, Dandoy CE, Myers KC, Lane A, Meller J, Medvedovic M, Chen J, Davies SM (2016) The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood 127(8):989\u2013996. doi:\n                    10.1182\/blood-2015-08-663435","journal-title":"Blood"},{"issue":"2","key":"3092_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","volume":"96","author":"BL Laskin","year":"2013","unstructured":"Laskin BL, Maisel J, Goebel J, Yin HJ, Luo G, Khoury JC, Davies SM, Jodele S (2013) Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transplantation 96(2):217\u2013223. doi:\n                    10.1097\/TP.0b013e31829807aa","journal-title":"Transplantation"},{"issue":"9","key":"3092_CR14","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","volume":"99","author":"FS de Fontbrune","year":"2015","unstructured":"de Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, Bay JO, Neven B, Moussi J, Simon L, Xhaard A, Resche-Riggon M, O'Meara A, Fremeaux-Bacchi V, Veyradier A, Socie G, Coppo P, de Latour RP (2015) Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC. Transplantation 99(9):1953\u20131959. doi:\n                    10.1097\/TP.0000000000000601","journal-title":"Transplantation"},{"issue":"4","key":"3092_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","volume":"20","author":"S Jodele","year":"2014","unstructured":"Jodele S, Fukuda T, Vinks A, Mizuno K, Laskin BL, Goebel J, Dixon BP, Teusink A, Pluthero FG, Lu L, Licht C, Davies SM (2014) Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 20(4):518\u2013525. doi:\n                    10.1016\/j.bbmt.2013.12.565","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"3092_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/bjh.12202","volume":"161","author":"R Peffault de Latour","year":"2013","unstructured":"Peffault de Latour R, Xhaard A, Fremeaux-Bacchi V, Coppo P, Fischer AM, Helley D, Socie G (2013) Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy. Br J Haematol 161(2):279\u2013280. doi:\n                    10.1111\/bjh.12202","journal-title":"Br J Haematol"},{"issue":"2","key":"3092_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","volume":"44","author":"JN George","year":"2004","unstructured":"George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB (2004) Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion 44(2):294\u2013304","journal-title":"Transfusion"},{"issue":"5","key":"3092_CR18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","volume":"82","author":"C Uderzo","year":"2006","unstructured":"Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M, Morreale G, Lanino E, Annaloro C, Volpe AD, Alessandrino P, Longoni D, Locatelli F, Sangalli H, Rovelli A (2006) Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 82(5):638\u2013644. doi:\n                    10.1097\/01.tp.0000230373.82376.46","journal-title":"Transplantation"},{"issue":"7","key":"3092_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371(7):654\u2013666. doi:\n                    10.1056\/NEJMra1312353","journal-title":"N Engl J Med"},{"key":"3092_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","volume":"66","author":"XL Zheng","year":"2015","unstructured":"Zheng XL (2015) ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med 66:211\u2013225. doi:\n                    10.1146\/annurev-med-061813-013241","journal-title":"Annu Rev Med"},{"issue":"2","key":"3092_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2141.2006.06126.x","volume":"134","author":"F Peyvandi","year":"2006","unstructured":"Peyvandi F, Siboni SM, Lambertenghi Deliliers D, Lavoretano S, De Fazio N, Moroni B, Lambertenghi Deliliers G, Mannuccio Mannucci P (2006) Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation. Br J Haematol 134(2):187\u2013195. doi:\n                    10.1111\/j.1365-2141.2006.06126.x","journal-title":"Br J Haematol"},{"issue":"8","key":"3092_CR22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW (2010) Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation 90(8):918\u2013926. doi:\n                    10.1097\/TP.0b013e3181f24e8d","journal-title":"Transplantation"},{"issue":"5","key":"3092_CR23","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","volume":"70","author":"PJ Tutschka","year":"1987","unstructured":"Tutschka PJ, Copelan EA, Klein JP (1987) Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 70(5):1382\u20131388","journal-title":"Blood"},{"issue":"9","key":"3092_CR24","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1182\/blood-2002-09-2955","volume":"102","author":"DG Maloney","year":"2003","unstructured":"Maloney DG, Molina AJ, Sahebi F, Stockerl-Goldstein KE, Sandmaier BM, Bensinger W, Storer B, Hegenbart U, Somlo G, Chauncey T, Bruno B, Appelbaum FR, Blume KG, Forman SJ, McSweeney P, Storb R (2003) Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood 102(9):3447\u20133454. doi:\n                    10.1182\/blood-2002-09-2955","journal-title":"Blood"},{"issue":"1121","key":"3092_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KSK, Beschormer WE (1987) Venoocclusive disease of the 1120 liver following bone marrow transplantation. Transplantation 44(1121):778\u2013783","journal-title":"Transplantation"},{"issue":"6","key":"3092_CR26","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 15(6):825\u2013828","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"3092_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ab.2006.06.022","volume":"358","author":"L Zhang","year":"2006","unstructured":"Zhang L, Lawson HL, Harish VC, Huff JD, Knovich MA, Owen J (2006) Creation of a recombinant peptide substrate for fluorescence resonance energy transfer-based protease assays. Anal Biochem 358(2):298\u2013300. doi:\n                    10.1016\/j.ab.2006.06.022","journal-title":"Anal Biochem"},{"issue":"8","key":"3092_CR28","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2009-01-195461","volume":"114","author":"TJ Raife","year":"2009","unstructured":"Raife TJ, Cao W, Atkinson BS, Bedell B, Montgomery RR, Lentz SR, Johnson GF, Zheng XL (2009) Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site. Blood 114(8):1666\u20131674. doi:\n                    10.1182\/blood-2009-01-195461","journal-title":"Blood"},{"issue":"6","key":"3092_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/0885066603258009","volume":"18","author":"WG Nichols","year":"2003","unstructured":"Nichols WG (2003) Management of infectious complications in the hematopoietic stem cell transplant recipient. J Intensive Care Med 18(6):295\u2013312. doi:\n                    10.1177\/0885066603258009","journal-title":"J Intensive Care Med"},{"issue":"12","key":"3092_CR30","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","volume":"122","author":"S Jodele","year":"2013","unstructured":"Jodele S, Licht C, Goebel J, Dixon BP, Zhang K, Sivakumaran TA, Davies SM, Pluthero FG, Lu L, Laskin BL (2013) Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood 122(12):2003\u20132007. doi:\n                    10.1182\/blood-2013-05-501445","journal-title":"Blood"},{"issue":"2","key":"3092_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","volume":"69","author":"CM Choi","year":"2009","unstructured":"Choi CM, Schmaier AH, Snell MR, Lazarus HM (2009) Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment. Drugs 69(2):183\u2013198. doi:\n                    10.2165\/00003495-200969020-00004","journal-title":"Drugs"},{"issue":"8","key":"3092_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","volume":"40","author":"ED Batts","year":"2007","unstructured":"Batts ED, Lazarus HM (2007) Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant 40(8):709\u2013719. doi:\n                    10.1038\/sj.bmt.1705758","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"3092_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, Ferrara J, Soiffer R, Giralt S (2005) Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11(8):571\u2013575. doi:\n                    10.1016\/j.bbmt.2005.06.001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"3092_CR34","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","volume":"8","author":"M Noris","year":"2012","unstructured":"Noris M, Mescia F, Remuzzi G (2012) STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 8(11):622\u2013633. doi:\n                    10.1038\/nrneph.2012.195","journal-title":"Nat Rev Nephrol"},{"issue":"3 Pt 2","key":"3092_CR35","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.lpm.2011.10.026","volume":"41","author":"JN George","year":"2012","unstructured":"George JN, Terrell DR, Vesely SK, Kremer Hovinga JA, Lammle B (2012) Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med 41(3 Pt 2):e177\u2013e188. doi:\n                    10.1016\/j.lpm.2011.10.026","journal-title":"Presse Med"},{"issue":"7","key":"3092_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ajh.20648","volume":"81","author":"H Nakamae","year":"2006","unstructured":"Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, Ohta K, Hino M (2006) Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Am J Hematol 81(7):525\u2013531. doi:\n                    10.1002\/ajh.20648","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3092-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:10:39Z","timestamp":1589627439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3092-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3092"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3092-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]},"assertion":[{"value":"17 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the patients provided written informed consent for the protocol, which was approved by our hospital\u2019s Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"XLZ is a member of the speakers\u2019 bureau and has received research support from Alexion and served as a consultant for Ablynx. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}